Allmed Solutions Ltd (TLV:ALMD)
Israel · Delayed Price · Currency is ILS · Price in ILA 33.50
+0.90 (2.76%)
Jun 3, 2026, 5:24 PM IDT
Allmed Solutions Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| - | - | - | - | 5.55 | |
Revenue Growth (YoY) | - | - | - | - | -42.95% |
Cost of Revenue | - | - | - | - | 2.46 |
Gross Profit | - | - | - | - | 3.08 |
Selling, General & Admin | 5 | 5.17 | 5.43 | 6.96 | 6.66 |
Research & Development | 8.02 | 5.9 | 5.24 | 5.33 | 5.6 |
Other Operating Expenses | - | - | 0.19 | 0.11 | -0.22 |
Operating Expenses | 13.02 | 11.07 | 10.85 | 12.41 | 12.04 |
Operating Income | -13.02 | -11.07 | -10.85 | -12.41 | -8.96 |
Interest Expense | -0.06 | -0.06 | -0.08 | -0.05 | -0.1 |
Interest & Investment Income | 1.44 | 2.12 | 1.75 | 0.02 | 0 |
Earnings From Equity Investments | - | - | -1.76 | -2.71 | -1.14 |
Currency Exchange Gain (Loss) | -2.5 | 0.26 | 0.46 | 2.05 | -1.01 |
Other Non Operating Income (Expenses) | 0.01 | - | 4.41 | 0.95 | -1.35 |
EBT Excluding Unusual Items | -14.12 | -8.75 | -6.08 | -12.15 | -12.54 |
Gain (Loss) on Sale of Investments | - | - | -4.94 | - | -0.22 |
Gain (Loss) on Sale of Assets | - | - | 12.61 | - | 18.85 |
Other Unusual Items | - | - | -0.17 | 0.01 | -3.39 |
Pretax Income | -14.12 | -8.75 | 1.42 | -12.14 | 2.7 |
Earnings From Continuing Operations | -14.12 | -8.75 | 1.42 | -12.14 | 2.7 |
Minority Interest in Earnings | - | - | - | - | 0.11 |
Net Income | -14.12 | -8.75 | 1.42 | -12.14 | 2.81 |
Net Income to Common | -14.12 | -8.75 | 1.42 | -12.14 | 2.81 |
Shares Outstanding (Basic) | 96 | 99 | 108 | 88 | 81 |
Shares Outstanding (Diluted) | 96 | 99 | 108 | 88 | 81 |
Shares Change (YoY) | -3.09% | -8.33% | 23.15% | 8.97% | 0.37% |
EPS (Basic) | -0.15 | -0.09 | 0.01 | -0.14 | 0.03 |
EPS (Diluted) | -0.15 | -0.09 | 0.01 | -0.14 | 0.03 |
Free Cash Flow | -12.13 | -8.14 | 7.02 | -10.65 | -5.52 |
Free Cash Flow Per Share | -0.13 | -0.08 | 0.07 | -0.12 | -0.07 |
Gross Margin | - | - | - | - | 55.60% |
Operating Margin | - | - | - | - | -161.55% |
Profit Margin | - | - | - | - | 50.64% |
Free Cash Flow Margin | - | - | - | - | -99.57% |
EBITDA | -12.84 | -10.86 | -10.38 | -11.86 | -7.9 |
EBITDA Margin | - | - | - | - | -142.40% |
D&A For EBITDA | 0.18 | 0.21 | 0.48 | 0.55 | 1.06 |
EBIT | -13.02 | -11.07 | -10.85 | -12.41 | -8.96 |
EBIT Margin | - | - | - | - | -161.55% |